tiprankstipranks
Trending News
More News >
Baxter International (BAX)
NYSE:BAX
US Market

Baxter International (BAX) Stock Forecast & Price Target

Compare
1,475 Followers
See the Price Targets and Ratings of:

BAX Analyst Ratings

Hold
10Ratings
Hold
3 Buy
6 Hold
1 Sell
Based on 10 analysts giving stock ratings to
Baxter
International
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

BAX Stock 12 Month Forecast

Average Price Target

$35.22
▲(12.31%Upside)
Based on 10 Wall Street analysts offering 12 month price targets for Baxter International in the last 3 months. The average price target is $35.22 with a high forecast of $40.00 and a low forecast of $28.00. The average price target represents a 12.31% change from the last price of $31.36.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"27":"$27","34":"$34","41":"$41","30.5":"$30.5","37.5":"$37.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":40,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$40.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":35.22,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$35.22</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":28,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$28.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[27,30.5,34,37.5,41],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2024","6":"Nov<br/>2024","9":"Feb<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,29.55,30.353846153846156,31.157692307692308,31.961538461538463,32.76538461538462,33.56923076923077,34.37307692307692,35.176923076923075,35.98076923076923,36.784615384615385,37.58846153846154,38.392307692307696,39.19615384615385,{"y":40,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,29.55,29.986153846153847,30.422307692307694,30.85846153846154,31.294615384615383,31.73076923076923,32.16692307692308,32.60307692307692,33.03923076923077,33.47538461538461,33.91153846153846,34.347692307692306,34.783846153846156,{"y":35.22,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,29.55,29.430769230769233,29.31153846153846,29.192307692307693,29.073076923076922,28.953846153846154,28.834615384615386,28.715384615384615,28.596153846153847,28.47692307692308,28.357692307692307,28.23846153846154,28.119230769230768,{"y":28,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":39.07,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":33.31,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":32.3,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":35.18,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":37.36,"date":1725148800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":36.34,"date":1727740800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":35.32,"date":1730419200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":33.2,"date":1733011200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":28.86,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":32.22,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":34.32,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":30.5,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":29.55,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$40.00Average Price Target$35.22Lowest Price Target$28.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on BAX
TipRanks AITipRanks
Not Ranked
TipRanks
$32
Hold
2.04%
Upside
Reiterated
06/10/25
Baxter International's overall stock score reflects a combination of mixed financial performance, neutral technical indicators, challenging valuation, and a positive earnings call. The significant factors influencing the score include operational challenges impacting profitability and the optimistic outlook from the earnings call, which suggests potential for future growth despite current difficulties.
UBS
$35
Hold
11.61%
Upside
Reiterated
06/11/25
UBS Sticks to Their Hold Rating for Baxter International (BAX)
Goldman Sachs Analyst forecast on BAX
David RomanGoldman Sachs
Goldman Sachs
$37
Buy
17.98%
Upside
Reiterated
06/10/25
Baxter International Poised for Growth: Buy Rating Affirmed Amid Strategic Initiatives and Promising Outlook
Citi
$34
Hold
8.42%
Upside
Reiterated
05/22/25
Baxter International (BAX) Gets a Hold from Citi
Argus Research Analyst forecast on BAX
Steven SilverArgus Research
Argus Research
$40
Buy
27.55%
Upside
Reiterated
05/05/25
Analysts Offer Insights on Healthcare Companies: Baxter International (NYSE: BAX) and Vera Therapeutics (NASDAQ: VERA)
Morgan Stanley Analyst forecast on BAX
Patrick WoodMorgan Stanley
Morgan Stanley
$30$28
Sell
-10.71%
Downside
Reiterated
05/05/25
Baxter International (BAX) Receives a Sell from Morgan Stanley
Jefferies
Hold
Reiterated
05/02/25
Analysts Offer Insights on Healthcare Companies: GeoVax Labs (NASDAQ: GOVX) and Baxter International (NYSE: BAX)
J.P. Morgan Analyst forecast on BAX
Robbie MarcusJ.P. Morgan
J.P. Morgan
$36$34
Hold
8.42%
Upside
Reiterated
05/02/25
J.P. Morgan Sticks to Their Hold Rating for Baxter International (BAX)
Stifel Nicolaus Analyst forecast on BAX
Rick WiseStifel Nicolaus
Stifel Nicolaus
$36
Buy
14.80%
Upside
Reiterated
05/02/25
Wall Street Analysts Are Bullish on Top Healthcare Picks
Wells Fargo Analyst forecast on BAX
Larry BiegelsenWells Fargo
Wells Fargo
$33
Hold
5.23%
Upside
Reiterated
05/01/25
Baxter International: Balancing Growth Potential and Tariff Challenges with a Hold Rating
TD Cowen
$40
Hold
27.55%
Upside
Reiterated
05/01/25
Balanced Outlook on Baxter International: Strong Performance with Margin Concerns
Barclays Analyst forecast on BAX
Matt MiksicBarclays
Barclays
$39$41
Buy
30.74%
Upside
Reiterated
03/07/25
Baxter International (BAX) Gets a Buy from Barclays
Evercore ISI Analyst forecast on BAX
Vijay KumarEvercore ISI
Evercore ISI
$42$44
Buy
40.31%
Upside
Reiterated
02/21/25
Evercore ISI Sticks to Their Buy Rating for Baxter International (BAX)
Bank of America Securities Analyst forecast on BAX
Travis SteedBank of America Securities
Bank of America Securities
$40
Hold
27.55%
Upside
Reiterated
02/20/25
Baxter International's 2025 Outlook: Hold Rating Amid Growth Potential and Leadership Transition
CFRA Analyst forecast on BAX
Unknown AnalystCFRA
Not Ranked
CFRA
$30
Sell
-4.34%
Downside
Downgraded
11/11/24
CFRA downgrades Baxter International (BAX) to Sell (nidday)CFRA downgraded Baxter International (NYSE: BAX) from Hold to Sell with a price target of $30.00.
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on BAX
TipRanks AITipRanks
Not Ranked
TipRanks
$32
Hold
2.04%
Upside
Reiterated
06/10/25
Baxter International's overall stock score reflects a combination of mixed financial performance, neutral technical indicators, challenging valuation, and a positive earnings call. The significant factors influencing the score include operational challenges impacting profitability and the optimistic outlook from the earnings call, which suggests potential for future growth despite current difficulties.
UBS
$35
Hold
11.61%
Upside
Reiterated
06/11/25
UBS Sticks to Their Hold Rating for Baxter International (BAX)
Goldman Sachs Analyst forecast on BAX
David RomanGoldman Sachs
Goldman Sachs
$37
Buy
17.98%
Upside
Reiterated
06/10/25
Baxter International Poised for Growth: Buy Rating Affirmed Amid Strategic Initiatives and Promising Outlook
Citi
$34
Hold
8.42%
Upside
Reiterated
05/22/25
Baxter International (BAX) Gets a Hold from Citi
Argus Research Analyst forecast on BAX
Steven SilverArgus Research
Argus Research
$40
Buy
27.55%
Upside
Reiterated
05/05/25
Analysts Offer Insights on Healthcare Companies: Baxter International (NYSE: BAX) and Vera Therapeutics (NASDAQ: VERA)
Morgan Stanley Analyst forecast on BAX
Patrick WoodMorgan Stanley
Morgan Stanley
$30$28
Sell
-10.71%
Downside
Reiterated
05/05/25
Baxter International (BAX) Receives a Sell from Morgan Stanley
Jefferies
Hold
Reiterated
05/02/25
Analysts Offer Insights on Healthcare Companies: GeoVax Labs (NASDAQ: GOVX) and Baxter International (NYSE: BAX)
J.P. Morgan Analyst forecast on BAX
Robbie MarcusJ.P. Morgan
J.P. Morgan
$36$34
Hold
8.42%
Upside
Reiterated
05/02/25
J.P. Morgan Sticks to Their Hold Rating for Baxter International (BAX)
Stifel Nicolaus Analyst forecast on BAX
Rick WiseStifel Nicolaus
Stifel Nicolaus
$36
Buy
14.80%
Upside
Reiterated
05/02/25
Wall Street Analysts Are Bullish on Top Healthcare Picks
Wells Fargo Analyst forecast on BAX
Larry BiegelsenWells Fargo
Wells Fargo
$33
Hold
5.23%
Upside
Reiterated
05/01/25
Baxter International: Balancing Growth Potential and Tariff Challenges with a Hold Rating
TD Cowen
$40
Hold
27.55%
Upside
Reiterated
05/01/25
Balanced Outlook on Baxter International: Strong Performance with Margin Concerns
Barclays Analyst forecast on BAX
Matt MiksicBarclays
Barclays
$39$41
Buy
30.74%
Upside
Reiterated
03/07/25
Baxter International (BAX) Gets a Buy from Barclays
Evercore ISI Analyst forecast on BAX
Vijay KumarEvercore ISI
Evercore ISI
$42$44
Buy
40.31%
Upside
Reiterated
02/21/25
Evercore ISI Sticks to Their Buy Rating for Baxter International (BAX)
Bank of America Securities Analyst forecast on BAX
Travis SteedBank of America Securities
Bank of America Securities
$40
Hold
27.55%
Upside
Reiterated
02/20/25
Baxter International's 2025 Outlook: Hold Rating Amid Growth Potential and Leadership Transition
CFRA Analyst forecast on BAX
Unknown AnalystCFRA
Not Ranked
CFRA
$30
Sell
-4.34%
Downside
Downgraded
11/11/24
CFRA downgrades Baxter International (BAX) to Sell (nidday)CFRA downgraded Baxter International (NYSE: BAX) from Hold to Sell with a price target of $30.00.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Baxter International

1 Month
xxx
Success Rate
11/22 ratings generated profit
50%
Average Return
-1.48%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of -1.48% per trade.
3 Months
xxx
Success Rate
6/14 ratings generated profit
43%
Average Return
-1.06%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 42.86% of your transactions generating a profit, with an average return of -1.06% per trade.
1 Year
Vijay KumarEvercore ISI
Success Rate
6/14 ratings generated profit
43%
Average Return
-1.78%
reiterated a buy rating 4 months ago
Copying Vijay Kumar's trades and holding each position for 1 Year would result in 42.86% of your transactions generating a profit, with an average return of -1.78% per trade.
2 Years
xxx
Success Rate
5/14 ratings generated profit
36%
Average Return
-3.90%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 35.71% of your transactions generating a profit, with an average return of -3.90% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

BAX Analyst Recommendation Trends

Rating
Jan 25
Feb 25
Mar 25
May 25
Jun 25
Strong Buy
0
0
0
0
0
Buy
3
6
7
8
4
Hold
4
8
7
11
7
Sell
2
2
1
2
1
Strong Sell
0
0
0
0
0
total
9
16
15
21
12
In the current month, BAX has received 4 Buy Ratings, 7 Hold Ratings, and 1 Sell Ratings. BAX average Analyst price target in the past 3 months is 35.22.
Each month's total comprises the sum of three months' worth of ratings.

BAX Financial Forecast

BAX Earnings Forecast

Next quarter’s earnings estimate for BAX is $0.61 with a range of $0.59 to $0.63. The previous quarter’s EPS was $0.55. BAX beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 34.21% of the time in the same period. In the last calendar year BAX has Outperformed its overall industry.
Next quarter’s earnings estimate for BAX is $0.61 with a range of $0.59 to $0.63. The previous quarter’s EPS was $0.55. BAX beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 34.21% of the time in the same period. In the last calendar year BAX has Outperformed its overall industry.

BAX Sales Forecast

Next quarter’s sales forecast for BAX is $2.82B with a range of $2.80B to $2.86B. The previous quarter’s sales results were $2.63B. BAX beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 69.09% of the time in the same period. In the last calendar year BAX has Outperformed its overall industry.
Next quarter’s sales forecast for BAX is $2.82B with a range of $2.80B to $2.86B. The previous quarter’s sales results were $2.63B. BAX beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 69.09% of the time in the same period. In the last calendar year BAX has Outperformed its overall industry.

BAX Stock Forecast FAQ

What is BAX’s average 12-month price target, according to analysts?
Based on analyst ratings, Baxter International’s 12-month average price target is 35.22.
    What is BAX’s upside potential, based on the analysts’ average price target?
    Baxter International has 12.31% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is BAX a Buy, Sell or Hold?
          Baxter International has a consensus rating of Hold which is based on 3 buy ratings, 6 hold ratings and 1 sell ratings.
            What is Baxter International’s price target?
            The average price target for Baxter International is 35.22. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $40.00 ,the lowest forecast is $28.00. The average price target represents 12.31% Increase from the current price of $31.36.
              What do analysts say about Baxter International?
              Baxter International’s analyst rating consensus is a Hold. This is based on the ratings of 10 Wall Streets Analysts.
                How can I buy shares of BAX?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis